We are live on ! Find out more
WHWK

Whitehawk Therapeutics
WHWK

46 hedge funds and large institutions have $294M invested in Whitehawk Therapeutics in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

217% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 6

120% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 5

39% more funds holding

Funds holding: 33 → 46 (+13)

5.08% more ownership

Funds ownership: 53.3% → 58.37% (+5.1%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

9% less capital invested

Capital invested by funds: $324M → $294M (-$29.9M)

Holders
46
Holders Change
+13
Holders Change %
+39.39%
% of All Funds
0.71%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
19
Increased
11
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$16.2M
2
State Street
State Street
Massachusetts
+$7.82M
3
BlackRock
BlackRock
New York
+$7.37M
4
GTC
Ghost Tree Capital
New York
+$5.02M
5
IC
Ikarian Capital
Texas
+$4.65M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$10.2M
2
BI
BVF Inc
California
-$6.22M
3
RSCM
Rock Springs Capital Management
Maryland
-$5.67M
4
O
OrbiMed
New York
-$5.49M
5
VC
Vivo Capital
California
-$3.11M
Name Holding Trade Value Shares
Change 		Change in
Stake
AICPI
26
ABG Innovation Capital Partners III
Hong Kong
$644K – – –
BFM
27
Boothbay Fund Management
New York
$603K +$627K +24,952 New
AA
28
ALPS Advisors
Colorado
$584K +$607K +24,174 New
UBS Group
29
UBS Group
Switzerland
$581K +$599K +23,854 +9,939%
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$530K +$551K +21,957 New
6CM
31
683 Capital Management
New York
$435K +$453K +18,025 New
SSA
32
Schonfeld Strategic Advisors
New York
$381K +$397K +15,800 New
Bank of New York Mellon
33
Bank of New York Mellon
New York
$273K +$284K +11,306 New
CSS
34
Cubist Systematic Strategies
Connecticut
$265K +$276K +10,975 New
AWP
35
Ascent Wealth Partners
New York
$241K +$251K +10,000 New
PA
36
Parallel Advisors
California
$155K – – –
US Bancorp
37
US Bancorp
Minnesota
$80K – – –
Morgan Stanley
38
Morgan Stanley
New York
$65K +$65.3K +2,600 +2,857%
Wells Fargo
39
Wells Fargo
California
$19K +$17.9K +714 +893%
Osaic Holdings
40
Osaic Holdings
Arizona
$6K – – –
TWC
41
TD Waterhouse Canada
Ontario, Canada
$5.68K +$5.83K +232 New
TRCT
42
Tower Research Capital (TRC)
New York
$4K +$3.27K +130 +325%
IAG
43
Investmark Advisory Group
Connecticut
$2K +$2.51K +100 New
Simplex Trading
44
Simplex Trading
Illinois
$2K +$2.51K +100 New
RCM
45
RA Capital Management
Massachusetts
– -$10.2M -347,668 Closed
OM
46
Opaleye Management
Massachusetts
– -$1.32M -45,020 Closed
Millennium Management
47
Millennium Management
New York
– -$832K -28,343 Closed
Acadian Asset Management
48
Acadian Asset Management
Massachusetts
– -$597K -20,343 Closed
NFG
49
Next Financial Group
Texas
– -$3K -100 Closed
1
2

WHWK Hedge Fund Activity: Q4 2021 in Review

46 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Whitehawk Therapeutics (WHWK) for Q4 2021, worth a combined $294M — down 9.2% from $324M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new WHWK positions and 6 closed out — a net gain of 13 holders — while 11 added to existing stakes and 5 trimmed.

The largest buyer was Vanguard Group, adding an estimated $16.2M. The largest seller was RA Capital Management, exiting entirely with an estimated $10.2M sold.

  • 46 institutional investors held Whitehawk Therapeutics (WHWK) as of Q4 2021, up from 33 in Q3 2021.
  • Funds reported $294M of Whitehawk Therapeutics stock for Q4 2021, down 9.2% quarter-over-quarter.
  • 19 funds opened new Whitehawk Therapeutics positions in Q4 2021 and 6 closed out, a net change of +13 holders.
  • The largest Whitehawk Therapeutics buyer in Q4 2021 was Vanguard Group, an estimated $16.2M added.
  • The largest Whitehawk Therapeutics seller in Q4 2021 was RA Capital Management, an estimated $10.2M sold.

Based on aggregated 13F filings for Q4 2021.